Brad N. Taylor, Ph.D.

Brad N. Taylor, Ph.D.

Dr. Brad Taylor has 17 years of experience commercializing products for scientists in both academia and industry before joining Nucleus Biologics. Most recently, Dr. Taylor was the Director of Global Marketing at HemaCare, supporting the needs of the cellular therapy industry. Prior to HemaCare, Dr. Taylor spent 11 years at PerkinElmer supporting in vivo imaging platforms and has held leadership roles in technical support, product management, and marketing. Dr. Taylor holds a M.S. in Microbiology and Immunology from Louisiana State University Health Sciences Center and a Ph.D. in Molecular Biology and Genetics from Friedrich-Alexander University in Germany.

Latest Articles

greenlab

Green Your Lab Today Using these 5 Methods

12 July 2022

ISO

Nucleus Biologics Earns ISO Certification

11 October 2022

Cell_Therapy_Conferences

Top 10 Cell Therapy Conferences to Attend

27 October 2022

Nucleus Biologics Wants Your CAR T Cells to Rock!

Nucleus Biologics Wants Your CAR T Cells to Rock!

12 December 2022

Top_Ten_Blog_Posts_2022

Top Ten Blog Posts of 2022

20 December 2022

CAR T Cell Therapy for Solid Tumors

11 June 2024

Improving the Efficacy of T Cell Therapies

25 June 2024